Swapnil Prabhakar Narale

Title: Innovations in Influenza Vaccination: The Contributions of Swapnil Prabhakar Narale

Introduction

Swapnil Prabhakar Narale is an accomplished inventor based in Pune, Maharashtra, India. He has made significant contributions to the field of vaccine development, particularly in the area of influenza vaccination. His innovative work focuses on creating safer and more effective vaccine compositions.

Latest Patents

Narale holds a patent for a "Stabilized live attenuated influenza vaccine compositions." This patent outlines compositions and methods for manufacturing a live attenuated influenza vaccine (LAIV) that can be delivered intranasally. The LAIV composition is designed to provide protection against influenza virus infections. The strains used in this vaccine are based on cold-adapted, temperature-sensitive, and attenuated phenotypes of master donor viruses (MDVs). These strains contain the surface glycoprotein genes of wild-type pandemic or seasonal influenza strains. Notably, the LAIV strains are adapted to grow in Madin Darby canine kidney (MDCK) cells, eliminating the need for eggs in large-scale vaccine manufacturing. The purification process is also simplified, as it does not involve chromatography steps. The LAIV composition includes one or more live attenuated influenza vaccine viruses and is free from polymers and surfactants.

Career Highlights

Narale is currently associated with the Serum Institute of India Private Limited, a leading organization in vaccine production. His work at the institute has been pivotal in advancing vaccine technology and improving public health outcomes.

Collaborations

Throughout his career, Narale has collaborated with notable colleagues, including Rajeev Mhalasakant Dhere and Leena Ravindra Yeolekar. These collaborations have contributed to the successful development of innovative vaccine solutions.

Conclusion

Swapnil Prabhakar Narale's contributions to the field of influenza vaccination exemplify the importance of innovation in public health. His patented work on live attenuated influenza vaccine compositions represents a significant advancement in vaccine technology.